FDA Issues Guidance on Immunogenicity Tests for Therapeutic Proteins

Drug Industry Daily
A A
The FDA released guidance for sponsors of therapeutic proteins on developing assays to assess immunogenicity during clinical trials.

To View This Article:

Login

Subscribe To Drug Industry Daily